Pretty pls show me a post that i was short below 7, because i wasnt. Just because you dont believe in a co doesnt mean you go short at any price
Why? Where have i been wrong. Im certainly not wrong on insider sales. Thats for sure. This company has nothing and you know it. Just read your recent posts on achn , you agree. So if i am full of it so are you. Cheers and good luck!
I shorted during after hours after that PR, and more at 16, made a killing. Hey i like this post of yours:
a.biopharm • Apr 21, 2015 1:06 PM Flag
0users liked this postsusers disliked this posts2Reply
"3102 is the most potent NS5A in development by far and was the primary reason such extreme viral reduction took place"...
binary_departure101 • Apr 21, 2015 1:11 PM Flag
1users liked this postsusers disliked this posts0Reply
but who needs it? where does it fit? GILD sales are crushing the competition, so not much incentive for them to take it..no?
I fully agree
And why would RA be involved in talks? Unless you are insinuating RA really runs this company? Now you might be onto something......and they sold over 100 mill $ last year......
Yep they must be in perpetual talks, managers havent bought in over a year and half and since it was under 3. Those are some negotiations
Conversely they were doing the type of same thing from 2.5 to 16......all so RA, ceo, cfo, chairman could DUMP millions of shares. Any buys recently by management at these bargain basement prices?? No? Lol
Guys read the scientific literature......or twitter.....big pharma is actively moving on from hep C to hep B. Check out tkmr, arwr, etc etc.....
Can you claim "best" based on 12 patients at 6 weeks? (Also any non responders in those 12? ) The market doesnt seem to agree. I wonder why?
Then why on earth hasnt it happened yet? Maybe achn should hurry up and run the 5a w more patients? How many patients in their last comprehensive trial?
Hopefully achn starts some real trials soon with the 5a so gild can compare it to the 4-5 other 5a s out there, the clock is ticking. Bmy is probably shopping their 5a around after having done very in depth trials on it.....
As oposed to you and mag who brag about buying at 15 then 13 then 11 and claim you are so smart when you could have shot the whole wad at 9s? Now thats rocket science lol
Check out a comparative chart of all 3 since 4/2 when PEIX announced amended merger terms moving up closure, you ll see what i mean
Rex and gpre by a considerable margin, as the market knows that the stock is about to reflect the positive earnings of both PEIX AND Aventine. Peix got a bargain.....as long as margins stay +.......
See PR dated 3/16 "Easton Pharmaceuticals Announces Memorandum of Understanding With Broken Coast Cannabis Ltd, a Health Canada Licensed MMPR Provider"